Infertility affects 10%–15% of people worldwide. While infertility is challenging for anyone who's impacted, people of LatinX heritage may face specific complexities, and we’ll address some of those in this course. Let’s start with the basics of fertility treatment.
For "natural" conception to occur, there are a few requirements. A person must grow a high quality egg, ovulate it, and have intercourse just before ovulation so that sperm is present. The sperm must be of reasonably high quality (see here) and both fallopian tubes must be open for the egg and sperm to meet. Finally, a healthy uterus is needed to absorb and nourish the resulting embryo and to carry the pregnancy.
When natural conception isn't happening (or can't happen), there are basically four ”fertility treatment” approaches available, each with their trade-offs on cost, burden, odds of success, and potential risks.
While approaches like “timed intercourse” and “oral medications” are often the least intensive, they’re also the least likely to deliver a baby.
Conversely, approaches like in vitro fertilization are intensive, but (age dependent) dramatically improve the odds of success, and for some patients, will be the only path to bringing home a child.
We should note, the success rates below reflect data on mostly Caucasian patients in their mid-30's and in the United States. As you’ll see in a later lesson, success rates may be lower for patients of LatinX heritage. Similarly, costs quoted below reflect general prices in a sample of regions, and even within those regions, prices can vary substantially.
For couples trying to conceive naturally, the odds of success rise dramatically if they try during a woman’s “fertile window”. As you can see, trying in the days immediately preceding ovulation raises the odds substantially.
Often, couples believe that “saving up” (restricting the number of days they have intercourse leading up to ovulation) improves the odds of success. However, as you can see from the data below, there’s no detriment in trying more often during the fertile window and clear benefit in trying at least three of the six days leading up to ovulation.
Generally speaking, as you can see below, if a woman or couple hasn’t conceived using timed intercourse after five months, the odds of conceiving each month drops precipitously.
To improve the odds of natural conception, a woman can take oral medications like Clomid (clomiphene) or Femara (letrozole). Taking these drugs improves the odds a woman ovulates an egg that can be fertilized or "superovulates" more than one egg to improve the odds of pregnancy. While the impact on success rates tends to be modest, the cost and burden also tend to be minimal compared with other treatments.
While we often lump Clomid and letrozole together, the truth is they are different. Clomid has been studied more extensively but remains in a woman’s system longer. For a subgroup of patients, the distinction does matter: specifically, PCOS (which may impact certain LatinX subpopulations in higher proportion) patents have better outcomes with letrozole.
With a few exceptions, after trying to conceive with Clomid or letrozole, for many patients the next step is to try intrauterine insemination. Intrauterine insemination (IUI), sometimes referred to as “artificial insemination”, is the process of placing sperm in a woman’s uterus. This procedure delivers sperm past the vagina and cervix (see the graphic below), both potential barriers for sperm, and into the uterus near the fallopian tubes, thereby raising the chances sperm will fertilize a woman’s egg.
While IUI is less intensive than options like IVF (which we’ll cover momentarily), IUI can still require a fair amount of time at a doctor’s office, and the costs can add up. For example, in the United States, the cost of an IUI cycle can range from $500 to $4,000 (in countries like Mexico the price is often closer to 10,000 MXN$) and depends on which, if any, medications are taken in the lead-up to the insemination (more on that in a moment).
We have an incredibly detailed course on IUI here that we suggest you look at if this becomes an option you want to consider.
However, these success rates are highly dependent on age. As you can see from a handful of studies below, IUI success rates decrease with age regardless of where treatment is practiced. To be certain, some clinics will see higher rates of success than what's quoted below, but even in those centers, rates of success decline with age. We should note, this chart is not meant to draw comparisons of rates of success between regions.
Yet, even for a woman under the age of 35 with no infertility diagnosis, the odds are likely that any given IUI will not work. This can be a devastating surprise, and so it’s important to get familiar with the odds of success for IUI.
Given the single-cycle failure rate for IUI, it’s common for women or couples to try multiple inseminations in back-to-back months.
IUI success rates and costs vary depending on which, if any, medications are used leading up to an insemination.
The chart below incorporates study data from two continents and shows the correlation of increasingly intensive drugs, higher success rates, but also higher risks (in the form of multiple gestation pregnancies—which can be dangerous both to the mother and child—we’ll cover that soon).
To illustrate, if a woman does IUI with no drugs, she may have a 1%–10% chance of delivering a child, and if so, a 0%–5% chance that delivery will result in twins. On the other hand, if a woman takes gonadotropin (injectable hormones) leading up to her IUI, there’s nearly a 15% chance she’ll deliver, and if she does, an (extremely high) 30% chance it will be with twins.
There’s the option to do a “natural” IUI cycle, and use no drugs at all, in which case, you’ll merely do monitoring to understand when ovulation is likely and have the insemination performed just before ovulation.
The best candidates for this option are women with “regular cycles”, meaning they have no ovulatory disorders.
In the data above, these natural cycles had the lowest chances of working, but also the lowest risk of resulting in a multiple gestation pregnancy like twins, triplets, or more.
The next level up are the medications most commonly used with IUI. These are oral medications like Clomid (clomiphene) or Femara (letrozole). These medications are fairly easy to take, typically cost less than a hundred dollars, and they do boost success rates per cycle into the low teens.
However, the chances that a resulting pregnancy is a multiple gestation pregnancy also rise.
Finally, taking these medications will probably step up the logistics involved in a cycle, because it’s more likely that your doctor will have you come in for monitoring appointments to ensure the medications are working properly—this is more time consuming and also adds some cost.
Generally speaking, many doctors are comfortable performing an IUI with these drugs: they feel the improved odds of success compensate for the increased (but still “tolerable”) risk, cost, and inconvenience.
Finally, the most intensive medications are gonadotropins—these are injections that are expensive (around $2,000 per cycle in some countries like the U.S. and far less in most other regions).
They moderately increase success rates over letrozole (Femara) or Clomid, but it’s rare that they would be recommended for IUI, because they are often more costly and many studies (including the one below published in the New England Journal of Medicine) reflect they drive up the risk of a multiple gestation delivery.
Many of the newsworthy stories of high-order multiple pregnancies you may have read about were the result of combining gonadotropins and IUI. A serious discussion about risks should happen between the patient and doctor before pushing ahead with IUI in conjunction with gonadotropins.
IVF, or in vitro fertilization, is a more intensive and expensive treatment option than IUI—it requires that eggs are surgically removed from the ovaries, that those eggs are inseminated with sperm in a laboratory, and that a resulting embryo is placed in a woman’s uterus with the hopes that it implants and leads to a healthy baby.
A hopeful parent might strongly consider IVF if:
They are mostly focused on getting pregnant as fast as possible. However, most patients still require multiple IVF cycles to deliver
IUI has not previously worked in the first 3–5 or so attempts
A woman has a medical condition (like blocked fallopian tubes) that renders IUI ineffective
A male partner suffers from “male factor infertility” and upon semen analysis, produces a “total motile count” (number of moving sperm) below 5–10 million
A hopeful parent or couple plans to have multiple children, across multiple pregnancies. IVF allows patients to create and freeze multiple embryos for future use
A woman has already frozen her eggs, and thus, completed the most expensive and intensive portion of the IVF process
A hopeful parent has a known genetic condition and wants to minimize the risk of transmission to their future children
Hopeful parent(s) have suffered through multiple pregnancy losses due to genetic abnormalities
IVF success rates tend to correlate closely with female age, regardless of geography, as you can see below. This chart is not meant to draw comparisons of success rates between regions or territories, as that would require far more data.
When British investigators looked at historical data, they noted more than half of women under age 40 deliver a child after three IVF cycles, whereas for women over the age of 40, rates of IVF success tend to be much lower.
As you’ll see below, when “donor eggs” (see our course here) are incorporated into the process, success rates climb quickly.
The same is also true in circumstances where a male partner has an underlying fertility issue (see our course here) and “donor sperm” is provided.
If a female partner has difficulty conceiving or carrying with embryos that appear to be of good quality, having a gestational carrier or surrogate also dramatically raises the odds of success.
As we mentioned, IVF is practiced differently in many parts of the world, but generally speaking there are a handful of basic steps (and decisions) involved. We’ll summarize those below, but if you want the full set of details, head to our comprehensive guide to IVF here.
A woman is usually given injectable hormones to make her ovaries develop as many eggs as they can (say, 8–20) instead of the usual 1–2 that would be matured each month. This continues for an average of 10 days until a “trigger shot” is taken to start the ovulation process where eggs become mature.
In some circumstances, doctors prefer to substitute out high levels of injectable hormones for lower doses or less-potent oral medications. For some (but not all) patients, this tends to lower success rates. For a closer analysis, see our lesson on IVF "protocols" here.
Eggs are surgically retrieved from the ovaries, and typically, anesthesia is used during the procedure. A doctor usually uses a vaginal ultrasound to guide a needle that suctions out each egg.
Over the next 3–7 days, a fertility clinic’s laboratory will take all of the collected, mature eggs and try to grow them into healthy embryos.
First, they fertilize the eggs with sperm either by surrounding an egg with sperm in a petri dish, or using ICSI, a micro-procedure where a single sperm is injected into an egg.
Then the laboratory will try to grow the embryos into either Day 3 “cleavage stage” embryos or heartier Day 5, 6, or 7 “blastocyst stage” embryos. Growing embryos to the “blastocyst stage” is challenging, and depending upon the region, it can be more or less common to find clinics able or prepared to do so.
Once embryos have reached the blastocyst stage, there is an option to remove a few cells and have them sent out for genetic testing, sometimes referred to as PGT or PGS screening. This testing can either test for a single genetic disorder that runs in your family history (PGT-M) or testing can predict if an embryo is likely or unlikely to lead to a healthy pregnancy (PGT-A). We have a detailed course on PGT-A here.
As you can see, implantation rates per embryo transfer are higher with PGT-A-tested and approved embryos than they are with untested embryos and are less likely to lead to a miscarriage.
However, this is not true in all populations. Below is data collected from 36 clinics on three continents that reflects the benefits of PGT-A that tend to most influence female patients ages 35 and older.
Credible experts disagree on the utility of PGT-A screening, unless a patient is looking to do testing to screen out embryos for a specific genetic disorder. We go into more detail on the topic to help you make your decision in our dedicated course here.
After developing embryos, whether or not genetic screening has been done, more clinics and patients are using the option to freeze all of their embryos, and then embryos will be transferred later on. For more on the decisions and trade-offs of freezing embryos, visit our lesson here.
An embryo will be transferred into the uterus with the hopes that it “implants” and leads to a healthy pregnancy. The safest option is to transfer one embryo at a time. When patients transfer more than one embryo per transfer, the risks (most dramatically for younger women) they'll conceive with twins or triplets rise. As you can see in the data below, multiple gestation pregnancies raise the risk to both the person carrying the pregnancy and to the offspring. As we’ll show in the next section, there’s reason to believe patients of LatinX heritage may be more likely to undergo transfers consisting of multiple embryos at one time, which again, drives an elevated risk.
Any embryos of reasonable quality that were not transferred will be frozen and can be used later, either in the event that the first transfer doesn’t work, or if it does work, for more children in the future.
In some senses, you can think of IVF like a funnel. Unfortunately, not every developed ovarian follicle will contain a mature egg, and not every mature egg will lead to a healthy embryo or a baby. At each stage throughout the process, you’ll lose something. That’s why the goal is to have a high number of eggs to start off with. Below is a sample summary of this funnel.
IVF prices vary dramatically by region, nuances of the treatment, levels of insurance coverage, and more. It’s common for patients to pay significantly more for treatment than the figures quoted by a fertility clinic. Often these quoted prices exclude the prices for required drugs (which can be meaningful) or “add-ons” (e.g. ICSI or embryo testing) the clinic may later insist upon.
To showcase in a U.S. context how drugs and add-ons can change the total cost for each cycle, below is a chart of what patients with no insurance coverage may pay in a handful of U.S. regions with larger LatinX populations.
In the U.S., it’s rare to have IVF covered by an employer’s insurance plan, and even if coverage exists, a woman or heterosexual couple may be asked to try a progression of timed intercourse, oral medication, and IUIs before receiving coverage for IVF.
Generally speaking, IVF costs and coverage vary. In many countries, a woman or couple will be asked to try multiple (less expensive) IUIs before IVF can be covered. Even if IVF is covered, certain aspects of the process (e.g. drugs, fertilization techniques, tests, ability to transfer multiple embryos at once) may not be. Finally, in many countries where IVF is covered, there can be lengthy delays to receive treatment, and oftentimes, a cap on female age, often 40–45, whereafter treatment won’t be covered.
We think there are a handful of criteria in determining whether one should start with IUI or IVF. We elucidate the factors below, though of course, prioritizing those factors is a personal choice.